|
US5410017A
(en)
*
|
1993-05-21 |
1995-04-25 |
Rohm And Haas Company |
Continuous thermal polycondensation process for preparing polypeptide polymers
|
|
DK2623605T3
(en)
|
2007-04-09 |
2019-03-25 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
|
US12358954B2
(en)
|
2012-05-15 |
2025-07-15 |
University Of Florida Research Foundation, Incorporated |
Capsid-modified rAAV vector compositions and methods therefor
|
|
EP3049527A4
(en)
|
2013-09-26 |
2017-08-16 |
University of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
WO2016126857A1
(en)
|
2015-02-03 |
2016-08-11 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
IL314171A
(en)
|
2015-09-28 |
2024-09-01 |
Univ Florida |
Methods and compositions for antibody-evading virus vectors
|
|
WO2017070476A2
(en)
*
|
2015-10-22 |
2017-04-27 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav3 capsid library
|
|
US11124546B2
(en)
|
2015-12-14 |
2021-09-21 |
The University Of North Carolina At Chapel Hill |
Modified capsid proteins for enhanced delivery of parvovirus vectors
|
|
CA3033125A1
(en)
*
|
2016-08-16 |
2018-02-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
CA3034089A1
(en)
*
|
2016-08-18 |
2018-02-22 |
The Regents Of The University Of California |
Crispr-cas genome engineering via a modular aav delivery system
|
|
EP3585883A4
(en)
|
2017-02-21 |
2021-04-14 |
University of Florida Research Foundation, Incorporated |
MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
|
|
US12359221B2
(en)
|
2017-05-05 |
2025-07-15 |
The Regents Of The University Of California |
Compositions and methods for expressing otoferlin
|
|
SI3645551T1
(sl)
*
|
2017-06-27 |
2024-06-28 |
Regeneron Pharmaceuticals, Inc. |
S tropizmi spremenjeni rekombinantni virusni vektorji in njihova uporaba za tarčni vnos genetskega materiala v človeške celice
|
|
EP3679148A4
(en)
*
|
2017-09-08 |
2021-06-09 |
Generation Bio Co. |
LIPID NANOPARTICLE FORMULATIONS FROM NONVIRAL, CAPSID-FREE DNA VECTORS
|
|
EP3740581A4
(en)
*
|
2018-01-16 |
2021-10-27 |
CLS Therapeutics Limited |
TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY
|
|
JP7389040B2
(ja)
*
|
2018-01-17 |
2023-11-29 |
メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド |
遺伝子治療のための修飾ｒＡＡＶキャプシドタンパク質
|
|
AU2019215152A1
(en)
|
2018-02-01 |
2020-08-20 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof
|
|
WO2019152841A1
(en)
|
2018-02-01 |
2019-08-08 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for pah gene transfer and methods of use thereof
|
|
CA3086942A1
(en)
*
|
2018-02-07 |
2019-08-15 |
Genethon |
Hybrid regulatory elements
|
|
US11306329B2
(en)
|
2018-02-19 |
2022-04-19 |
City Of Hope |
Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
|
|
EP3781187A4
(en)
*
|
2018-03-29 |
2021-12-22 |
Asklepios Biopharmaceutical, Inc. |
TROPICAL RECOMBINANT AAV6 LIVER VECTORS TO Bypass NEUTRALIZATION
|
|
CA3095179A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
MX2020010465A
(es)
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus para direccionamiento a tejidos oftalmicos.
|
|
BR112020020266A2
(pt)
|
2018-04-03 |
2021-01-19 |
Stridebio, Inc. |
Vetores de vírus com evasão de anticorpos
|
|
CN112703016B
(zh)
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
US20210363192A1
(en)
*
|
2018-04-27 |
2021-11-25 |
Spark Therapeutics, Inc. |
Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same
|
|
JP7142815B2
(ja)
*
|
2018-06-21 |
2022-09-28 |
株式会社遺伝子治療研究所 |
ヒト肝臓への遺伝子導入のためのアデノ随伴ウイルスビリオン
|
|
JP2021530218A
(ja)
|
2018-07-11 |
2021-11-11 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. |
血液脳関門を超える薬剤の送達のための方法および組成物
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
WO2020079256A1
(en)
*
|
2018-10-19 |
2020-04-23 |
Genethon |
Modulation, monitoring and prediction of the immune response directed against aav gene therapy vectors
|
|
CN113924109A
(zh)
*
|
2019-01-18 |
2022-01-11 |
巴斯德研究所 |
Aav介导的基因疗法恢复耳畸蛋白基因
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
WO2020163761A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
CN113727992A
(zh)
|
2019-03-21 |
2021-11-30 |
斯特里迪比奥公司 |
重组腺相关病毒载体
|
|
EP3736330A1
(en)
*
|
2019-05-08 |
2020-11-11 |
European Molecular Biology Laboratory |
Modified adeno-associated virus (aav) particles for gene therapy
|
|
AU2020299026A1
(en)
*
|
2019-07-04 |
2022-01-20 |
Children's Medical Research Institute |
Methods and AAV vectors for in vivo transduction
|
|
EP3997214B1
(en)
*
|
2019-07-11 |
2023-08-02 |
Centre National de la Recherche Scientifique |
Chemically-modified adeno-associated virus
|
|
EP4010357A2
(en)
|
2019-08-09 |
2022-06-15 |
University of Florida Research Foundation, Incorporated |
Aav capsid variants for targeting human glioblastoma cells
|
|
US20220325296A1
(en)
*
|
2019-09-12 |
2022-10-13 |
The Broad Institute, Inc. |
Engineered adeno-associated virus capsids
|
|
MX2022004353A
(es)
|
2019-10-17 |
2022-07-19 |
|
Casete de transferencia de aav.
|
|
CN114787180A
(zh)
|
2019-10-17 |
2022-07-22 |
斯特里迪比奥公司 |
用于治疗c型尼曼-匹克病的腺相关病毒载体
|
|
TWI896570B
(zh)
|
2019-10-30 |
2025-09-11 |
美商迪賽博治療公司 |
使用耳畸蛋白雙載體系統治療感覺神經性聽力損失之組合物及方法
|
|
WO2021108467A1
(en)
*
|
2019-11-25 |
2021-06-03 |
University Of Florida Research Foundation, Incorporated |
Novel aav3b variants that target human hepatocytes and evade the humoral immune response
|
|
US20230049066A1
(en)
*
|
2019-11-25 |
2023-02-16 |
University Of Florida Research Foundation, Incorporated |
Novel aav3b variants that target human hepatocytes in the liver of humanized mice
|
|
CA3167290A1
(en)
*
|
2020-01-10 |
2021-07-15 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for delivery of immunotherapy agents across the blood-brain barrier to treat brain cancer
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
IL295741A
(en)
|
2020-04-01 |
2022-10-01 |
Univ Florida |
Dual aav-myo7a vectors with improved safety for the treatment of ush1b
|
|
CA3177268A1
(en)
|
2020-05-05 |
2021-11-11 |
The University Of North Carolina At Chapel Hill |
Modified adeno-associated virus 5 capsids and uses thereof
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
JP2023542614A
(ja)
|
2020-08-19 |
2023-10-11 |
サレプタ セラピューティクス， インコーポレイテッド |
レット症候群の治療のためのアデノ随伴ウイルスベクター
|
|
MX2023005446A
(es)
|
2020-11-11 |
2023-07-18 |
European Molecular Biology Laboratory |
Particulas virales modificadas para terapia genica.
|
|
WO2022119826A1
(en)
*
|
2020-12-01 |
2022-06-09 |
Research Institute At Nationwide Children's Hospital |
Products and methods for inhibition of expression of peripheral myelin protein-22
|
|
CA3212043A1
(en)
*
|
2021-03-19 |
2022-09-22 |
Ucl Business Plc |
Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathy
|
|
CN113647359A
(zh)
*
|
2021-08-15 |
2021-11-16 |
芜湖职业技术学院 |
注射衣霉素诱导急性肝损伤小鼠模型的构建方法
|
|
CN118201947B
(zh)
|
2021-10-28 |
2025-03-21 |
上海天泽云泰生物医药有限公司 |
腺相关病毒衣壳
|
|
WO2023201368A2
(en)
*
|
2022-04-15 |
2023-10-19 |
Dyno Therapeutics, Inc. |
Capsid variants and methods of using the same
|
|
GB202407863D0
(en)
|
2024-06-03 |
2024-07-17 |
Purespring Therapeutics Ltd |
Methods
|
|
WO2026001958A1
(zh)
*
|
2024-06-24 |
2026-01-02 |
黄菁 |
Aav载体、aav载体的组合、构建aml pdx和mm pdx非人动物的方法及构建免疫系统人源化非人动物的方法
|
|
WO2026024045A1
(ko)
*
|
2024-07-22 |
2026-01-29 |
한국생명공학연구원 |
변이체 캡시드를 포함하는 아데노-연관 바이러스 및 이의 용도
|
|
CN119380820B
(zh)
*
|
2024-10-10 |
2025-06-17 |
四川大学华西医院 |
一种aav2衣壳蛋白变体设计方法、系统和存储介质
|